Rebates to pharmacy benefit managers are a hidden contributor to high drug prices

(By Douglas Hoey for STAT)

In the furor over high drug prices, both Congress and the media have largely focused on the role played by drug companies such as Turing Pharmaceuticals, Valeant1, and Mylan2. Another contributor — pharmacy benefit managers and the rebates they get from drug companies — is only now getting the attention it deserves. Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or